Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2025/11/08

DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 1.65% to $657.53 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.13% to 6,728.80 and the Dow Jones Industrial Average rising 0.16% to 46,987.10.

This was the stock's third consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 21.20% below its 52-week high of $834.42, which the company achieved on November 11th.

The stock outperformed some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 1.46% to $320.20, Moderna Inc. (MRNA) rose 0.86% to $24.54, and Gilead Sciences Inc. (GILD) fell 3.70% to $118.84.

Trading volume (688,267) remained 366,986 below its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 7, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 07, 2025 16:44 ET (21:44 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10